Zika Vaccines Market - Industry Insights, Size, Shares, Trends, Outlook, and Opportunity Analysis, 2018–2026

1. Zika Vaccines Market - Industry Insights, Size, Shares, Trends, Outlook, Zika Vaccines Market - Industry Insights, Size, Shares, Trends, Outlook, and Opportunity Analysis, 2018–2026 and Opportunity Analysis, 2018–2026 Zika vaccines Zika vaccines are developed for immunization & prevention against diseases caused by Zika virus. This virus belongs to genus Flavivirus and is transmitted by Aedes mosquitoes. The virus can also be transmitted through blood transfusion, sexual contact or from infected pregnant women to the fetus. Diagnosis of this infection is confirmed by detecting viral DNA through PCR. However, only 1 in 4 people with zika infection are prone to develop symptoms. In November 2016, the World Health Organization (WHO) declared that zika infection no longer constitutes a Public Health Emergency of International Concern (PHEIC) as major cases of zika virus were asymptomatic. Request Sample Copy of Research Request Sample Copy of Research Report: Report:https://www.coherentmarketinsights.com/insight/request-sample/413 https://www.coherentmarketinsights.com/insight/request-sample/413 Continuous increase in human clinical trials and rise in number of zika cases will Continuous increase in human clinical trials and rise in number of zika cases will drive the growth of Zika vaccines market drive the growth of Zika vaccines market As of March 2016, 67 companies and research institutions were working on various kinds of R&D projects and clinical trials aided to develop effective vaccines against zika virus. The FDA approved the first human clinical trial for GLS–5700 in June 2016, a zika vaccine being developed by Inovio Pharmaceuticals. Further in 2017, a grant was approved for phase 2 clinical trials for a DNA vaccine conducted by NIAID’s Vaccine Research Center (VRC).

2. Increasing awareness among the population would aid in controlling the incidence rate of zika infection. The WHO implemented a global framework for creating public awareness through its Zika Strategic Response Framework and Joint Plan in February 2016. This plan outlines all the points to be taken care of at the time of infections. In June 2016, WHO Regional Office for Europe developed a training curriculum to increase awareness by the publication of Zika Risk Assessment for European Region. High investment costs required for R&D and the development of effective zika virus vaccines serves as a restraining factor for the global zika vaccines market. While major of the Zika virus cases occur in tropical regions such as Brazil, Paraguay, Venezuela, Colombia and Suriname, there are higher chances of mosquito infections in tropical areas of the U.S. like Texas and Florida. According to Pan American Health Organization, around 1,246 suspected and confirmed cases were reported between epidemiological week (EW) 10 and EW 14 of 2016 in the sub region which involves Brazil, Argentina, Peru and Ecuador. Some key players key players operating in the zika vaccines market are Cerus Corporation, Biken Inc, GlaxoSmithKline plc, Bharat Biotech International Pvt. Ltd, GeneOne Life Science, Inovio Pharmaceuticals, Immunovaccine Inc., NewLink Genetics Corp. and Sanofi S.A. Inquire Here Before Purchase: Inquire Here Before Purchase:https://www.coherentmarketinsights.com/insight/talk-to- https://www.coherentmarketinsights.com/insight/talk-to- analyst/413 analyst/413 Zika Vaccines Market Taxonomy: Zika Vaccines Market Taxonomy: There are different types of vaccines that provide protection against Zika virus: • DNA-based vaccines • Inactivated vaccines • Live-attenuated vaccines • mRNA vaccines • Genetically engineered vaccines Global market by application: • Therapeutic Vaccines • Preventive Vaccines Global market by end user: • Hospitals • Clinics About Coherent Market Insights About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services,

3. and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: Email: sales@coherentmarketinsights.com sales@coherentmarketinsights.com